The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
Open accessAbstract
BACKGROUND: Among patients with aortic stenosis who are at intermediate or high risk for death with surgery, major outcomes are similar with transcatheter aortic-valve replacement (TAVR) and surgical aortic-valve replacement. There is insufficient evidence regarding the comparison of the two procedures in patients who are at low risk. METHODS: We randomly assigned patients with severe aortic stenosis and low surgical risk to undergo either TAVR with transfemoral placement of a balloon-expandable valve or surgery. The primary end point was a composite of death, stroke, or rehospitalization at 1 year. Both noninferiority testing (with a prespecified margin of 6 percentage points) and superiority testing were performed in the as-treated population. RESULTS: At 71 centers, 1000 patients underwent randomization. The mean age of the patients was 73 years, and the mean Society of Thoracic Surgeons risk score was 1.9% (with scores ranging from 0 to 100% and higher scores indicating a greater risk of death within 30 days after the procedure). The Kaplan-Meier estimate of the rate of the primary composite end point at 1 year was significantly lower in the TAVR group than in the surgery group (8.5% vs. 15.1%; absolute difference, -6.6 percentage points; 95% confidence interval [CI], -10.8 to -2.5; P<0.001 for noninferiority; hazard ratio, 0.54; 95% CI, 0.37 to 0.79; P = 0.001 for superiority). At 30 days, TAVR resulted in a lower rate of stroke than surgery (P = 0.02) and in lower rates of death or stroke (P = 0.01) and new-onset atrial fibrillation (P<0.001). TAVR also resulted in a shorter index hospitalization than surgery (P<0.001) and in a lower risk of a poor treatment outcome (death or a low Kansas City Cardiomyopathy Questionnaire score) at 30 days (P<0.001). There were no significant between-group differences in major vascular complications, new permanent pacemaker insertions, or moderate or severe paravalvular regurgitation. CONCLUSIONS: Among patients with severe aortic stenosis who were at low surgical risk, the rate of the composite of death, stroke, or rehospitalization at 1 year was significantly lower with TAVR than with surgery. (Funded by Edwards Lifesciences; PARTNER 3 ClinicalTrials.gov number, NCT02675114.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
Leon, M. B., Smith, C. R., Mack, M., Miller, D. C., Moses, J. W., Svensson, L. G., Tuzcu, E. M., Webb, J. G., Fontana, G. P., Makkar, R. R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008232 · Cited by 7,205
Self-citationTranscatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
Smith, C. R., Leon, M. B., Mack, M. J., Miller, D. C., Moses, J. W., Svensson, L. G., Tuzcu, E. M., Webb, J. G., Fontana, G. P., Makkar, R. R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103510 · Cited by 6,345
Self-citation2017 ESC/EACTS Guidelines for the management of valvular heart disease
Baumgartner, H., Falk, V., Bax, J. J., De Bonis, M., Hamm, C., Holm, P. J., Iung, B., Lancellotti, P., Lansac, E., Rodriguez Muñoz, D., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx391 · Cited by 6,243
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
Leon, M. B., Smith, C. R., Mack, M. J., Makkar, R. R., Svensson, L. G., Kodali, S. K., Thourani, V. H., Tuzcu, E. M., Miller, D. C., Herrmann, H. C., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1514616 · Cited by 5,053
Self-citationNishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.011 · Cited by 3,339
Self-citationCribier, A., Eltchaninoff, H., Bash, A., Borenstein, N., Tron, C., Bauer, F., Derumeaux, G., Anselme, F., Laborde, F., & Leon, M. B. (2002) · Circulation · doi:10.1161/01.cir.0000047200.36165.b8 · Cited by 3,172
Self-citationTranscatheter Mitral-Valve Repair in Patients with Heart Failure
Stone, G. W., Lindenfeld, J., Abraham, W. T., Kar, S., Lim, D. S., Mishell, J. M., Whisenant, B., Grayburn, P. A., Rinaldi, M., Kapadia, S. R., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1806640 · Cited by 3,017
Self-citationSurgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients
Reardon, M. J., Van Mieghem, N. M., Popma, J. J., Kleiman, N. S., Søndergaard, L., Mumtaz, M., Adams, D. H., Deeb, G. M., Maini, B., Gada, H., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1700456 · Cited by 3,009
Self-citationTranscatheter Aortic-Valve Replacement with a Self-Expanding Prosthesis
Adams, D. H., Popma, J. J., Reardon, M. J., Yakubov, S. J., Coselli, J. S., Deeb, G. M., Gleason, T. G., Buchbinder, M., Hermiller, J., Kleiman, N. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1400590 · Cited by 2,902
Mack, M. J., Leon, M. B., Smith, C. R., Miller, D. C., Moses, J. W., Tuzcu, E. M., Webb, J. G., Douglas, P. S., Anderson, W. N., Blackstone, E. H., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60308-7 · Cited by 1,739
Self-citation
Cited by
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987
Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Cheng, S., Delling, F. N., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000950 · Cited by 5,784
2021 ESC/EACTS Guidelines for the management of valvular heart disease
Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab395 · Cited by 5,685
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686
Self-citationMartin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000932 · Cited by 2,449
Self-citationAuthors/Task Force Members:, McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2333 · Cited by 2,171
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
Glikson, M., Nielsen, J. C., Kronborg, M. B., Michowitz, Y., Auricchio, A., Barbash, I. M., Barrabés, J. A., Boriani, G., Braunschweig, F., Brignole, M., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab364 · Cited by 2,019
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.018 · Cited by 1,982
Self-citationJankowski, J., Floege, J., Fliser, D., Böhm, M., & Marx, N. (2021) · Circulation · doi:10.1161/circulationaha.120.050686 · Cited by 1,904
Généreux, P., Piazza, N., Alu, M. C., Nazif, T., Hahn, R. T., Pibarot, P., Bax, J. J., Leipsic, J. A., Blanke, P., Blackstone, E. H., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.02.038 · Cited by 1,313
Self-citationMartin, S. S., Aday, A. W., Allen, N. B., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Bansal, N., Beaton, A. Z., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001303 · Cited by 1,080
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.035 · Cited by 1,075
Self-citation2025 ESC/EACTS Guidelines for the management of valvular heart disease
Praz, F., Borger, M. A., Lanz, J., Marin-Cuartas, M., Abreu, A., Adamo, M., Ajmone Marsan, N., Barili, F., Bonaros, N., Cosyns, B., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf194 · Cited by 1,072
STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement
Carroll, J. D., Mack, M. J., Vemulapalli, S., Herrmann, H. C., Gleason, T. G., Hanzel, G., Deeb, G. M., Thourani, V. H., Cohen, D. J., Desai, N., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.09.595 · Cited by 1,018
Self-citationVARC-3 WRITING COMMITTEE, Généreux, P., Piazza, N., Alu, M. C., Nazif, T., Hahn, R. T., Pibarot, P., Bax, J. J., Leipsic, J. A., Blanke, P., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa799 · Cited by 915
Self-citation2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
Glikson, M., Nielsen, J. C., Kronborg, M. B., Michowitz, Y., Auricchio, A., Barbash, I. M., Barrabés, J. A., Boriani, G., Braunschweig, F., Brignole, M., et al. (2022) · EP Europace · doi:10.1093/europace/euab232 · Cited by 914
Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement
Makkar, R. R., Thourani, V. H., Mack, M. J., Kodali, S. K., Kapadia, S., Webb, J. G., Yoon, S.-H., Trento, A., Svensson, L. G., Herrmann, H. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1910555 · Cited by 832
Self-citationTranscatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years
Mack, M. J., Leon, M. B., Thourani, V. H., Pibarot, P., Hahn, R. T., Genereux, P., Kodali, S. K., Kapadia, S. R., Cohen, D. J., Pocock, S. J., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2307447 · Cited by 635
Self-citation2021 ESC/EACTS Guidelines for the management of valvular heart disease
Beyersdorf, F., Vahanian, A., Milojevic, M., Praz, F., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., et al. (2021) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezab389 · Cited by 622
Self-citationA Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement
Dangas, G. D., Tijssen, J. G. P., Wöhrle, J., Søndergaard, L., Gilard, M., Möllmann, H., Makkar, R. R., Herrmann, H. C., Giustino, G., Baldus, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1911425 · Cited by 552
Self-citationEarly Surgery or Conservative Care for Asymptomatic Aortic Stenosis
Kang, D.-H., Park, S.-J., Lee, S.-A., Lee, S., Kim, D.-H., Kim, H.-K., Yun, S.-C., Hong, G.-R., Song, J.-M., Chung, C.-H., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1912846 · Cited by 537
Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., et al. (2022) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2022.05.006 · Cited by 527
Siontis, G. C. M., Overtchouk, P., Cahill, T. J., Modine, T., Prendergast, B., Praz, F., Pilgrim, T., Petrinic, T., Nikolakopoulou, A., Salanti, G., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz275 · Cited by 474
Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation
Brouwer, J., Nijenhuis, V. J., Delewi, R., Hermanides, R. S., Holvoet, W., Dubois, C. L. F., Frambach, P., De Bruyne, B., van Houwelingen, G. K., Van Der Heyden, J. A. S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2017815 · Cited by 421
Poor Long-Term Survival in Patients With Moderate Aortic Stenosis
Strange, G., Stewart, S., Celermajer, D., Prior, D., Scalia, G. M., Marwick, T., Ilton, M., Joseph, M., Codde, J., & Playford, D. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.08.004 · Cited by 412
2021 ESC/EACTS Guidelines for the management of valvular heart disease
Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., et al. (2022) · EuroIntervention · doi:10.4244/eij-e-21-00009 · Cited by 372
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease
Izumi, C., Eishi, K., Ashihara, K., Arita, T., Otsuji, Y., Kunihara, T., Komiya, T., Shibata, T., Seo, Y., Daimon, M., et al. (2020) · Circulation Journal · doi:10.1253/circj.cj-20-0135 · Cited by 367
Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation
Nijenhuis, V. J., Brouwer, J., Delewi, R., Hermanides, R. S., Holvoet, W., Dubois, C. L. F., Frambach, P., De Bruyne, B., van Houwelingen, G. K., Van Der Heyden, J. A. S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915152 · Cited by 351
Management of Conduction Disturbances Associated With Transcatheter Aortic Valve Replacement
Rodés-Cabau, J., Ellenbogen, K. A., Krahn, A. D., Latib, A., Mack, M., Mittal, S., Muntané-Carol, G., Nazif, T. M., Sondergaard, L., Urena, M., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.07.014 · Cited by 344
Self-citationAortic Valve Stenosis: From Basic Mechanisms to Novel Therapeutic Targets
Goody, P. R., Hosen, M. R., Christmann, D., Niepmann, S. T., Zietzer, A., Adam, M., Bönner, F., Zimmer, S., Nickenig, G., & Jansen, F. (2020) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.313067 · Cited by 331
Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk
Leon, M. B., Mack, M. J., Hahn, R. T., Thourani, V. H., Makkar, R., Kodali, S. K., Alu, M. C., Madhavan, M. V., Chau, K. H., Russo, M., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.12.052 · Cited by 325
Self-citationCerebral Embolic Protection during Transcatheter Aortic-Valve Replacement
Kapadia, S. R., Makkar, R., Leon, M., Abdel-Wahab, M., Waggoner, T., Massberg, S., Rottbauer, W., Horr, S., Sondergaard, L., Karha, J., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2204961 · Cited by 325
Self-citationMakkar, R. R., Yoon, S.-H., Leon, M. B., Chakravarty, T., Rinaldi, M., Shah, P. B., Skipper, E. R., Thourani, V. H., Babaliaros, V., Cheng, W., et al. (2019) · JAMA · doi:10.1001/jama.2019.7108 · Cited by 316
Self-citationSelf-Expanding or Balloon-Expandable TAVR in Patients with a Small Aortic Annulus
Herrmann, H. C., Mehran, R., Blackman, D. J., Bailey, S., Möllmann, H., Abdel-Wahab, M., Ben Ali, W., Mahoney, P. D., Ruge, H., Wood, D. A., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2312573 · Cited by 306
Coronary Artery Disease and Transcatheter Aortic Valve Replacement
Faroux, L., Guimaraes, L., Wintzer-Wehekind, J., Junquera, L., Ferreira-Neto, A. N., del Val, D., Muntané-Carol, G., Mohammadi, S., Paradis, J.-M., & Rodés-Cabau, J. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.06.012 · Cited by 304
Bicuspid Aortic Valve Morphology and Outcomes After Transcatheter Aortic Valve Replacement
Yoon, S.-H., Kim, W.-K., Dhoble, A., Milhorini Pio, S., Babaliaros, V., Jilaihawi, H., Pilgrim, T., De Backer, O., Bleiziffer, S., Vincent, F., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.07.005 · Cited by 295
Self-citationReduced Leaflet Motion after Transcatheter Aortic-Valve Replacement
De Backer, O., Dangas, G. D., Jilaihawi, H., Leipsic, J. A., Terkelsen, C. J., Makkar, R., Kini, A. S., Veien, K. T., Abdel-Wahab, M., Kim, W.-K., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1911426 · Cited by 293
Self-citationJørgensen, T. H., Thyregod, H. G. H., Ihlemann, N., Nissen, H., Petursson, P., Kjeldsen, B. J., Steinbrüchel, D. A., Olsen, P. S., & Søndergaard, L. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab375 · Cited by 287
Lanz, J., Kim, W.-K., Walther, T., Burgdorf, C., Möllmann, H., Linke, A., Redwood, S., Thilo, C., Hilker, M., Joner, M., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32220-2 · Cited by 281
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR
Van Mieghem, N. M., Unverdorben, M., Hengstenberg, C., Möllmann, H., Mehran, R., López-Otero, D., Nombela-Franco, L., Moreno, R., Nordbeck, P., Thiele, H., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2111016 · Cited by 271
2020 ACC/AHA guideline for the management of patients with valvular heart disease
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.04.002 · Cited by 279
Self-citationNext-generation tissue-engineered heart valves with repair, remodelling and regeneration capacity
Fioretta, E. S., Motta, S. E., Lintas, V., Loerakker, S., Parker, K. K., Baaijens, F. P. T., Falk, V., Hoerstrup, S. P., & Emmert, M. Y. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0422-8 · Cited by 262
Thiele, H., Kurz, T., Feistritzer, H.-J., Stachel, G., Hartung, P., Eitel, I., Marquetand, C., Nef, H., Doerr, O., Lauten, A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa036 · Cited by 262
Frailty and Comprehensive Geriatric Assessment
Lee, H., Lee, E., & Jang, I.-Y. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e16 · Cited by 260
Transcatheter or Surgical Treatment of Aortic-Valve Stenosis
Blankenberg, S., Seiffert, M., Vonthein, R., Baumgartner, H., Bleiziffer, S., Borger, M. A., Choi, Y.-H., Clemmensen, P., Cremer, J., Czerny, M., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2400685 · Cited by 260
Sammour, Y., Krishnaswamy, A., Kumar, A., Puri, R., Tarakji, K. G., Bazarbashi, N., Harb, S., Griffin, B., Svensson, L., Wazni, O., et al. (2021) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2020.09.063 · Cited by 255
Self-citationCalcific Aortic Stenosis: A Review
Otto, C. M., Newby, D. E., & Hillis, G. S. (2024) · JAMA · doi:10.1001/jama.2024.16477 · Cited by 97
Hoagland, A., & Kipping, S. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.02.014 · Cited by 68
“The minimally-invasive nature of TAVI makes it suitable for patients at intermediate or high risk for mortality from traditional open surgical methods 101,102 ; conditional on risk, TAVI is cost-effective relative to open surgical methods.”
BackgroundDamluji, A. A., Bernacki, G., Afilalo, J., Lyubarova, R., Orkaby, A. R., Kwak, M. J., Hummel, S., Kirkpatrick, J. N., Maurer, M. S., Wenger, N., et al. (2024) · JACC: Advances · doi:10.1016/j.jacadv.2024.100877 · Cited by 41
Transcriptional profiling of normal, stenotic, and regurgitant human aortic valves
Greene, C. L., Jaatinen, K. J., Wang, H., Koyano, T. K., Bilbao, M. S., & Woo, Y. J. (2020) · Genes · doi:10.3390/genes11070789 · Cited by 30
Evaluation of recipients with significant comorbidity - patients with cardiovascular disease
Tsochatzis, E. A., Watt, K. D., VanWagner, L. B., Verna, E. C., & Berzigotti, A. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.023 · Cited by 22
Risk of Total Events With Icosapent Ethyl
Granger, C. B., Nelson, A. J., & Pagidipati, N. J. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.492 · Cited by 8
Metadata
- Authors
- Mack, M. J., Leon, M. B., Thourani, V. H., Makkar, R., Kodali, S. K., Russo, M., Kapadia, S. R., Malaisrie, S. C., Cohen, D. J., Pibarot, P., Leipsic, J., Hahn, R. T., Blanke, P., Williams, M. R., McCabe, J. M., Brown, D. L., Babaliaros, V., Goldman, S., Szeto, W. Y., Genereux, P., Pershad, A., Pocock, S. J., Alu, M. C., Webb, J. G., & Smith, C. R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2019-05-02
- Volume
- 380
- Issue
- 18
- Pages
- 1695-1705
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2921388585
- Cited by
- 4,847
- References
- 38
- FWCI
- 445.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.